<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="sma-xli" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">sma-xli</book-part-id>
      <title-group>
        <title>Spinal Muscular Atrophy, X-Linked Infantile</title>
        <alt-title alt-title-type="alt-title">Synonym: XL-SMA</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Baumbach-Reardon</surname>
            <given-names>Lisa</given-names>
          </name>
          <degrees>PhD, FACMG</degrees>
          <aff>Associate Research Professor and Director, TGEN Clinical DNA Diagnostic Laboratory<break/>Translational Genomics Research Institute<break/>Phoenix, Arizona</aff>
          <email>lbaumbach@tgen.org</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sacharow</surname>
            <given-names>Stephanie J</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Division of Genetics and Genomics<break/>Boston Children's Hospital<break/>Boston, Massachusetts</aff>
          <email>stephanie.sacharow@childrens.harvard.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahearn</surname>
            <given-names>Mary Ellen</given-names>
          </name>
          <degrees>MS</degrees>
          <aff>CLIA Lab Manager<break/>Translational Genomics Research Institute<break/>Phoenix, Arizona</aff>
          <email>meahearn@tgen.org</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>30</day>
          <month>10</month>
          <year>2008</year>
        </date>
        <date date-type="updated">
          <day>13</day>
          <month>9</month>
          <year>2012</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="sma" document-type="chapter">Spinal Muscular Atrophy</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="sca1" document-type="chapter">Spinocerebellar Ataxia Type 1</related-object>
      <abstract id="sma-xli.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>X-linked infantile spinal muscular atrophy (XL-SMA) is characterized by congenital hypotonia and areflexia and evidence of degeneration and loss of anterior horn cells (i.e., lower motor neurons) in the spinal cord and brain stem. Often congenital contractures and/or fractures are present. Intellect is normal. Life span is shortened because of progressive ventilatory insufficiency resulting from chest muscle involvement.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of XL-SMA is based on clinical findings; evidence of degeneration and loss of anterior horn cells in the spinal cord and brain stem; normal <italic toggle="yes">SMN1</italic> molecular genetic testing; and family history consistent with X-linked inheritance. <italic toggle="yes">UBA1</italic> is the only gene currently known to be associated with XL-SMA.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Assure adequate caloric intake by caloric supplementation and/or gastrostomy feedings as necessary; manage constipation with diet; provide rigorous pulmonary toilet, supplemental oxygen, and noninvasive ventilatory support; discuss "do not attempt to resuscitate" status with the family before respiratory failure occurs. Orthopedic consultation and physical and occupational therapy to manage contractures.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Precautions against infection.</p>
          <p><italic toggle="yes">Surveillance:</italic> Routine evaluations by a multidisciplinary team, including neurologic evaluation; assessment of pulmonary function, caloric intake, and weight gain; evaluation for scoliosis and/or kyphosis.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>XL-SMA is inherited in an X-linked manner. Carrier females have a 50% chance of transmitting the pathogenic variant with each pregnancy. Males who inherit the pathogenic variant will be affected; females who inherit the pathogenic variant will be carriers and will usually not be affected. Affected males do not reproduce. Carrier testing for family members at risk and prenatal testing for at-risk pregnancies are available if the <italic toggle="yes">UBA1</italic> pathogenic variant has been identified in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="sma-xli.Diagnosis">
        <title>Diagnosis</title>
        <sec id="sma-xli.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The diagnosis of X-linked infantile spinal muscular atrophy (XL-SMA) should be considered in children who meet the following criteria:</p>
          <list list-type="bullet">
            <list-item>
              <p>Congenital hypotonia and areflexia on physical examination</p>
            </list-item>
            <list-item>
              <p>Congenital contractures and/or fractures</p>
            </list-item>
            <list-item>
              <p>Digital contractures at birth. These usually remain throughout the child&#x02019;s life.</p>
            </list-item>
            <list-item>
              <p>Evidence of degeneration and loss of anterior horn cells (i.e., lower motor neurons) in the spinal cord and brain stem</p>
            </list-item>
            <list-item>
              <p>Normal <italic toggle="yes">SMN1</italic> molecular genetic testing to rule out autosomal recessive <related-object link-type="booklink" source-id="gene" document-id="sma" document-type="chapter">spinal muscular atrophy</related-object></p>
            </list-item>
            <list-item>
              <p>Male gender in a simplex case (i.e., a single occurrence in a family) or X-linked pattern of inheritance in families with more than one affected individual</p>
            </list-item>
          </list>
        </sec>
        <sec id="sma-xli.Testing">
          <title>Testing</title>
          <p>Electromyogram (EMG) should demonstrate findings of denervation.</p>
          <sec id="sma-xli.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">UBA1</italic> (previously referred to as <italic toggle="yes">UBE1</italic>) is the only gene in which mutation is known to cause XL-SMA.</p>
            <p><bold>Evidence for locus heterogeneity.</bold> Linkage to the X chromosome region Xp11.3-q11.1 has been demonstrated in families with X-linked SMA without pathogenic variants observed in <italic toggle="yes">UBA1</italic> [<xref ref-type="bibr" rid="sma-xli.REF.kobayashi.1995.1213">Kobayashi et al 1995</xref>, <xref ref-type="bibr" rid="sma-xli.REF.dressman.2007.52">Dressman et al 2007</xref>].</p>
            <p><bold>Clinical testing.</bold> Sequence analysis of select exons (exon 15) or of the entire coding region</p>
            <table-wrap id="sma-xli.T.summary_of_molecular_genetic_t" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in X-Linked Infantile Spinal Muscular Atrophy</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_1_2">Test Method</th>
                    <th id="hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_1_3">Variants Detected&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                  </tr>
                  <tr>
                    <th headers="hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_1_4" id="hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Affected Males&#x000a0;<sup>4</sup></th>
                    <th headers="hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_1_4" id="hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Carrier Females</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">UBA1</italic>
                    </td>
                    <td headers="hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_1_4 hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                    <td headers="hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_1_4 hd_h_sma-xli.T.summary_of_molecular_genetic_t_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="sma-xli.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="sma-xli" object-id="sma-xli.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="sma-xli.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="sma-xli.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="sma-xli.TF.1.3">
                  <label>3. </label>
                  <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
                </fn>
                <fn id="sma-xli.TF.1.4">
                  <label>4. </label>
                  <p>Five families detected so far with <italic toggle="yes">UBA1</italic> pathogenic variants with complete cosegregation of the disease [<xref ref-type="bibr" rid="sma-xli.REF.dressman.2007.52">Dressman et al 2007</xref>, <xref ref-type="bibr" rid="sma-xli.REF.ramser.2008.188">Ramser et al 2008</xref>]</p>
                </fn>
                <fn id="sma-xli.TF.1.5">
                  <label>5. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="sma-xli.TF.1.6">
                  <label>6. </label>
                  <p>Sequence analysis of genomic DNA cannot detect (multi)exon or whole-gene deletions on the X chromosome in carrier females.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="sma-xli.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Molecular genetic testing of <italic toggle="yes">SMN1</italic> to rule out autosomal recessive <related-object link-type="booklink" source-id="gene" document-id="sma" document-type="chapter">SMA</related-object></p>
            </list-item>
            <list-item>
              <p>Sequence analysis of select exons (exon 15) or of the entire coding region of <italic toggle="yes">UBA1</italic></p>
              <p>Note: To date, all pathogenic variants detected have been in exon 15.</p>
            </list-item>
          </list>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the pathogenic variant in the family.</p>
          <p>Note: Carriers are heterozygotes for this X-linked disorder and are usually unaffected.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant in the family.</p>
        </sec>
      </sec>
      <sec id="sma-xli.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="sma-xli.Clinical_Description">
          <title>Clinical Description</title>
          <p>X-linked infantile spinal muscular atrophy (XL-SMA) is characterized by severe hypotonia and areflexia with loss of anterior horn cells in the spinal cord (i.e., lower motor neurons). The disease course is similar to that in the most severe forms of classic autosomal recessive SMA caused by mutation of <italic toggle="yes">SMN1:</italic> SMA type 0 (SMA0) and SMA type I (SMA1) (see <related-object link-type="booklink" source-id="gene" document-id="sma" document-type="chapter">Spinal Muscular Atrophy</related-object>). In SMA0, prenatal onset of weakness and poor intrauterine movement results in congenital contractures. In SMA1, motor skills regress before age six months; affected children are never able to sit independently.</p>
          <p>The weakness of XL-SMA is often prenatal in onset, manifest as polyhydramnios and poor movement <italic toggle="yes">in utero</italic> that results in congenital contractures. (Note: The term &#x0201c;arthrogryposis&#x0201d; is used to describe the presence of multiple congenital contractures of any cause.) Some neonates with XL-SMA are born with fractures that are perhaps related to poor fetal movement and subsequent bone fragility.</p>
          <p>The most consistent features of XL-SMA are anterior horn cell disease and contractures (especially digital contractures) with or without fractures.</p>
          <p>The weakness of XL-SMA is progressive. Affected infants may achieve some early motor milestones, but the extent varies among families.</p>
          <p>Other features of XL-SMA that are variably present include mild micrognathia, digital contractures, kyphosis, scoliosis, and cryptorchidism.</p>
          <p>Cognitive ability, observed during an often-limited life span, appears to be normal in those with documented XL-SMA.</p>
          <p>As in SMA1, the greatest morbidity in XL-SMA may be restrictive lung disease, which is usually in proportion to the child&#x02019;s weakness and can be further complicated by aspiration and infection [<xref ref-type="bibr" rid="sma-xli.REF.iannaccone.2007.974">Iannaccone 2007</xref>].</p>
          <p>Children with XL-SMA usually die from respiratory failure by age two years; however, the age at death ranges from the neonatal period to adolescence, the latter in those exceptional cases in which extensive respiratory and medical support are provided.</p>
          <p>Note: Individuals with a clinical picture consistent with SMA type II or type III have not been tested for pathogenic variants in <italic toggle="yes">UBA1</italic>; thus, it is not yet known if individuals with milder SMA phenotypes have <italic toggle="yes">UBA1</italic> pathogenic variants.</p>
          <p>Female carriers of XL-SMA are usually unaffected.</p>
        </sec>
        <sec id="sma-xli.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No genotype-phenotype correlations are evident.</p>
        </sec>
        <sec id="sma-xli.Penetrance">
          <title>Penetrance</title>
          <p>Evidence suggests that the disorder is fully penetrant in hemizygous males.</p>
        </sec>
        <sec id="sma-xli.Nomenclature">
          <title>Nomenclature</title>
          <p>XL-SMA has also been called:</p>
          <list list-type="bullet">
            <list-item>
              <p>X-linked lethal infantile SMA</p>
            </list-item>
            <list-item>
              <p>Infantile X-linked SMA</p>
            </list-item>
            <list-item>
              <p>X-linked arthrogryposis multiplex congenita</p>
            </list-item>
            <list-item>
              <p>Distal X-linked AMC</p>
            </list-item>
            <list-item>
              <p>X-linked arthrogryposis type I, AMCX1</p>
            </list-item>
            <list-item>
              <p>SMAX2</p>
              <p>Note: SMAX1 is Kennedy disease (<related-object link-type="booklink" source-id="gene" document-id="kennedy" document-type="chapter">spinal and bulbar muscular atrophy</related-object>), an unrelated X-linked, adult-onset disease.</p>
            </list-item>
          </list>
        </sec>
        <sec id="sma-xli.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of XL-SMA is unknown. To date, 14 multigenerational families with affected family members have been identified throughout North America, Europe, Mexico, and Thailand [Author, personal observation]. This includes the family described by <xref ref-type="bibr" rid="sma-xli.REF.greenberg.1988.217">Greenberg et al [1988]</xref>.</p>
        </sec>
      </sec>
      <sec id="sma-xli.Genetically_Related_Allelic_Diso">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No other phenotypes are known to be associated with mutation of <italic toggle="yes">UBA1.</italic></p>
      </sec>
      <sec id="sma-xli.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of X-linked infantile spinal muscular atrophy (XL-SMA) caused by mutation of <italic toggle="yes">UBA1</italic> includes classic autosomal recessive SMA caused by mutation of <italic toggle="yes">SMN1</italic> and the genetically heterogeneous category of arthrogryposis (<xref ref-type="table" rid="sma-xli.T.features_of_xlinked_sma_compar">Table 2</xref>).</p>
        <table-wrap id="sma-xli.T.features_of_xlinked_sma_compar" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Features of X-Linked SMA Compared to <italic toggle="yes">SMN1</italic>-Related SMA and Isolated Non-Progressive Arthrogryposis</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_1">Features</th>
                <th id="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_2">XL-SMA</th>
                <th id="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3" valign="middle" colspan="5" align="left" scope="colgroup" rowspan="1">Autosomal Recessive SMA Type</th>
                <th id="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_4" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_4">Arthrogryposis&#x000a0;<sup>1</sup></th>
              </tr>
              <tr>
                <th headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3" id="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">0</th>
                <th headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3" id="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">I</th>
                <th headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3" id="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">II</th>
                <th headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3" id="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">III</th>
                <th headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3" id="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">IV</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Multiple contractures</bold>
                </td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Fractures</bold>
                </td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1;</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1;</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1;</td>
              </tr>
              <tr>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Hypotonia</bold>
                </td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1;</td>
              </tr>
              <tr>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Muscle weakness</bold>
                </td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1;</td>
              </tr>
              <tr>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Motor regression</bold>
                </td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1;</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1;</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">-</td>
              </tr>
              <tr>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Normal cognition</bold>
                </td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Absent tendon reflexes</bold>
                </td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">+ (70%)</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1;</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1;</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1;</td>
              </tr>
              <tr>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Myopathic facies</bold>
                </td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1;</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1;</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">-</td>
              </tr>
              <tr>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Neurogenic atrophy</bold>
                </td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1;</td>
              </tr>
              <tr>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Denervation by EMG</bold>
                </td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1;</td>
              </tr>
              <tr>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Anterior horn cell loss</bold>
                </td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_3 hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_sma-xli.T.features_of_xlinked_sma_compar_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x000b1;</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="sma-xli.TF.2.1">
              <label>1. </label>
              <p>Isolated non-progressive</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <sec id="sma-xli.SMA_Types_by_Inheritance_Pattern">
          <title>SMA Types by Inheritance Pattern</title>
          <sec id="sma-xli.Classic_Autosomal_Recessive_Spin">
            <title>Classic Autosomal Recessive Spinal Muscular Atrophy</title>
            <p><related-object link-type="booklink" source-id="gene" document-id="sma" document-type="chapter"><bold>SMA</bold></related-object><bold>,</bold> caused by mutation in <italic toggle="yes">SMN1</italic>, is characterized by loss of anterior horn cells with secondary muscle loss and weakness. SMA is classified by age of onset and maximum function achieved:</p>
            <list list-type="bullet">
              <list-item>
                <p>SMA1 (onset age &#x0003c;6 months)</p>
              </list-item>
              <list-item>
                <p>SMA2 (onset age 6-12 months)</p>
              </list-item>
              <list-item>
                <p>SMA3 (onset age &#x0003e;12 months)</p>
              </list-item>
              <list-item>
                <p>SMA4 (adult onset)</p>
              </list-item>
            </list>
            <p>SMA0 has been proposed for prenatal onset with severe joint contractures. Expression of <italic toggle="yes">SMN1</italic> pathogenic variants is modified by the copy number of <italic toggle="yes">SMN2</italic>.</p>
          </sec>
          <sec id="sma-xli.Other_Autosomal_Recessive_SMA_no">
            <title>Other Autosomal Recessive SMA (non-<italic toggle="yes">SMN</italic>)</title>
            <p><bold>Lethal congenital contracture syndrome (LCCS)</bold> is characterized by fetal akinesia sequence leading to multiple joint contractures and death in utero typically before 32 weeks&#x02019; gestation. Pathologic findings are anterior horn motor neuron degeneration and degeneration of descending tracts in the spinal cord. The highest gene frequency is in a genetically isolated subpopulation in northeastern Finland [<xref ref-type="bibr" rid="sma-xli.REF.m_kel_bengs.1998.506">M&#x000e4;kel&#x000e4;-Bengs et al 1998</xref>]. Candidate gene screening of a linkage region on 9q34 led to identification of a single-base pair substitution in <italic toggle="yes">GLE1</italic> in 29 unrelated Finnish families diagnosed with LCCS1 [<xref ref-type="bibr" rid="sma-xli.REF.nousiainen.2008.155">Nousiainen et al 2008</xref>]. <italic toggle="yes">GLE1</italic> pathogenic variants are also causative of LAAHD (lethal arthrogyposis with anterior horn cell disease), a disorder that is allelic to LCCS1 [<xref ref-type="bibr" rid="sma-xli.REF.nousiainen.2008.155">Nousiainen et al 2008</xref>]. LCCS differs from SMA in that the descending tracts in the spinal cord are preserved in SMA.</p>
            <p><bold>Pontocerebellar hypoplasia with spinal muscular atrophy (pontocerebellar hypoplasia type 1)</bold> is characterized by hypoplasia of the olivary nuclei, pons, and cerebellum and progressive anterior horn cell loss. Hypotonia and weakness are usually noted in the newborn period and can be associated with congenital joint contractures and areflexia. Early presence of tongue fasciculations is similar to SMA1; however, ocular, bulbar, and facial abnormalities are distinct from classic SMA. Most die of respiratory failure in the first year of life. Survivors have failure to thrive and intellectual disability. Spinal cord pathology shows anterior horn cell loss; demyelination may also be present. Affected sibling pairs and occasional parental consanguinity suggests autosomal recessive inheritance [<xref ref-type="bibr" rid="sma-xli.REF.ryan.2000.180">Ryan et al 2000</xref>, <xref ref-type="bibr" rid="sma-xli.REF.rudniksch_neborn.2003.10">Rudnik-Sch&#x000f6;neborn et al 2003</xref>]. See <related-object link-type="booklink" source-id="gene" document-id="exosc3-pc-hypo-p" document-type="chapter"><italic toggle="yes">EXOSC3</italic>-Related Pontocerebellar Hypoplasia</related-object>.</p>
            <p><bold>Spinal muscular atrophy with respiratory distress type 1 (SMARD1)</bold> is characterized by diaphragmatic paralysis in the first few months of life. Most affected infants have intrauterine growth retardation; many are born prematurely. Many have decreased fetal movement, and some have congenital foot contractures. All have early respiratory failure with a normally shaped thorax and diaphragmatic eventration. Weakness starts distally in the limbs, and extends to full paralysis. Nerve biopsy may show axonal degeneration; muscle biopsy shows neurogenic changes with fiber hypertrophy and atrophy. Mutation of <italic toggle="yes">IGHMBP2</italic> encoding the immunoglobulin micro-binding protein 2 is causative [<xref ref-type="bibr" rid="sma-xli.REF.grohmann.2003.719">Grohmann et al 2003</xref>].</p>
          </sec>
          <sec id="sma-xli.Autosomal_Dominant_SMA">
            <title>Autosomal Dominant SMA</title>
            <p><bold>Autosomal dominant (AD) SMA</bold> with onset in childhood and AD SMA with onset in adulthood are usually considered two separate entities. AD SMA is extremely rare in childhood, accounting for less than 2% of childhood SMA; however, up to 30% of adult-onset SMA may be transmitted in an AD manner [<xref ref-type="bibr" rid="sma-xli.REF.rietschel.1992.65">Rietschel et al 1992</xref>].</p>
            <p>Childhood-onset AD SMA usually presents between birth and age eight years. The course is usually mild, but with variable expression. Affected individuals lose the ability to walk at varying ages, often not for several decades. Life expectancy may be significantly diminished. Unlike adult-onset AD SMA, the symptoms are not limited to proximal muscles.</p>
            <p>One type of adult-onset AD SMA is proximal SMA, which presents with marked proximal muscle involvement. Onset is usually between ages 30 and 40 years, and does not occur before age 20 years. The disease course of adult-onset AD SMA tends to be much more rapid than that of childhood-onset AD SMA, with most affected individuals losing the ability to run within five years of onset. Life expectancy averages 20 years after onset; thus, life span is shortened to about age 50 or 60 years.</p>
            <p>Both childhood- and adult-onset AD SMA have nearly complete penetrance. However, some families have members with childhood onset and others with adult onset, suggesting that in some families the same underlying pathogenic variant may be responsible for both early and late onset [<xref ref-type="bibr" rid="sma-xli.REF.rietschel.1992.65">Rietschel et al 1992</xref>].</p>
            <p><bold>Scapuloperoneal spinal muscular atrophy,</bold> an AD form of SMA, which is allelic to hereditary motor and sensory neuropathy type IIC (HMSNIIC), also known as <related-object link-type="booklink" source-id="gene" document-id="cmt2c" document-type="chapter">Charcot-Marie-Tooth disease type 2C</related-object> (CMT2C), results from mutation of <italic toggle="yes">TRPV4</italic>, the gene encoding transient receptor potential cation channel subfamily V member 4 [<xref ref-type="bibr" rid="sma-xli.REF.deng.2010.165">Deng et al 2010</xref>]. Scapuloperoneal disorders are characterized by progressive weakness in a scapular and peroneal distribution, and severe fiber-type grouping and atrophy of both type 1 and type 2 fibers [<xref ref-type="bibr" rid="sma-xli.REF.deng.2010.165">Deng et al 2010</xref>]. AD transmission with variable expressivity and possible anticipation in subsequent generations have been observed. Other features include congenital absence of muscles, laryngeal palsy, and progressive distal weakness and atrophy [<xref ref-type="bibr" rid="sma-xli.REF.delong.1992.905">DeLong &#x00026; Siddique 1992</xref>].</p>
            <p><bold>Congenital benign spinal muscular atrophy</bold> is described as congenital <italic toggle="yes">non-progressive</italic> atrophy and weakness of the lumbar paraspinal muscles and lower limb musculature associated with contractures [<xref ref-type="bibr" rid="sma-xli.REF.frijns.1994.192">Frijns et al 1994</xref>]. Some children present with poor running and jumping, whereas others in the same family have congenital contractures. Involvement of upper limb and cranial musculature is variable. Although some affected individuals have normal nerve conduction velocities and action potentials, some have had concentric needle investigations that indicate neurogenic abnormalities such as reduced interference pattern, giant motor unit potentials in some muscle groups, and signs of denervation and reinnervation. In affected family members serum CK concentrations ranged between normal to twice the upper limit of normal. Muscle biopsy from the index case showed evidence for a neurogenic disorder, with group fiber atrophy with type 1 fiber predominance. The inheritance pattern was most consistent with AD but could also be X-linked or mitochondrial. Linkage analysis excluded linkage to <italic toggle="yes">SMN1</italic>.</p>
          </sec>
          <sec id="sma-xli.Other_XLinked_Forms_of_SMA">
            <title>Other X-Linked Forms of SMA</title>
            <p>X-linked distal SMA (DSMAX), described by <xref ref-type="bibr" rid="sma-xli.REF.takata.2004.224">Takata et al [2004]</xref>, has features similar to <related-object link-type="booklink" source-id="gene" document-id="cmt" document-type="chapter">Charcot Marie Tooth hereditary neuropathy</related-object>, including distal weakness; atrophy of the muscles of the lower limbs, particularly in the tibioperoneal compartment; and pes cavus. Symptoms start in the first decade and progress slowly. Muscle weakness and atrophy of the upper extremities, predominantly the hands, occurs later. Affected males remain ambulatory. Electrophysiologic studies show a distal neurogenic EMG pattern; muscle biopsy shows a mixed neurogenic and myogenic pattern; sural nerve biopsy is normal [<xref ref-type="bibr" rid="sma-xli.REF.takata.2004.224">Takata et al 2004</xref>]. <xref ref-type="bibr" rid="sma-xli.REF.kennerson.2010.343">Kennerson et al [2010]</xref> identified two pathogenic variants in <italic toggle="yes">ATP7A</italic> in affected males from two families. <italic toggle="yes">ATP7A</italic> encodes a copper-transporting P-type ATPase. The pathogenic variants are located in a conserved region in the carboxyl half of <italic toggle="yes">ATP7A</italic> and are not part of the copper transporter&#x02019;s known critical functional domains. Pathogenic variants in <italic toggle="yes">ATP7A</italic> have previously been associated with <related-object link-type="booklink" source-id="gene" document-id="menkes" document-type="chapter">Menkes disease</related-object>. They are loss-of-function variants, including splice-site variants, deletions, nonsense and missense variants within the critical functional domain of <italic toggle="yes">ATP7A,</italic> or variants that cause misfolding of the protein [<xref ref-type="bibr" rid="sma-xli.REF.hsi.2004.165">Hsi &#x00026; Cox 2004</xref>].</p>
          </sec>
          <sec id="sma-xli.Other_NonSMN_Disorders_with_SMA">
            <title>Other Non-<italic toggle="yes">SMN</italic> Disorders with SMA Phenotype</title>
            <p>Other individuals who meet diagnostic criteria for SMA, but have normal <italic toggle="yes">SMN1</italic> testing, have been described, suggesting the presence of an SMA type that is not associated with <italic toggle="yes">SMN1</italic> pathogenic variants and that may be inherited in an autosomal recessive or X-linked manner [<xref ref-type="bibr" rid="sma-xli.REF.nevo.1998.193">Nevo et al 1998</xref>, <xref ref-type="bibr" rid="sma-xli.REF.felderhoffmueser.2002.718">Felderhoff-Mueser et al 2002</xref>]. It is also known, based on previous DNA linkage studies in suspected XL-SMA families, that at least one phenocopy of this disorder does not map to the <italic toggle="yes">UBA1</italic> region and may well be a very rare autosomal recessive disease mimicking SMA [<xref ref-type="bibr" rid="sma-xli.REF.gerritsen.2003">Gerritsen et al 2003</xref>].</p>
          </sec>
        </sec>
        <sec id="sma-xli.Arthrogryposis">
          <title>Arthrogryposis</title>
          <p>Arthrogryposis is defined as multiple congenital contractures and absent flexion creases.</p>
          <p>Arthrogryposis multiplex congenita is etiologically heterogeneous: underlying etiologies can include central nervous system causes, neurogenic effects, fetal constraint, and intrauterine vascular disruption (e.g., amyoplasia). In addition, <related-object link-type="booklink" source-id="gene" document-id="cms" document-type="chapter">congenital myasthenic syndromes</related-object> are genetic disorders of the neuromuscular junction that may present with arthrogryposis. Arthrogryposis is often classified by affected body area (e.g., distal arthrogryposis); generalized arthrogryposis is referred to as arthrogryposis multiplex congenita. It is typically considered non-progressive, although the clinical course of arthrogryposis of neurogenic etiology follows that of the underlying condition. Inheritance pattern varies by etiology; many genes are known to be associated with different arthrogryposis types.</p>
          <p><bold>X-linked arthrogryposis.</bold> Of the many cases of X-linked arthrogryposis described in the literature, some may have been caused by mutation of <italic toggle="yes">UBA1</italic> and perhaps other unknown genes. X-linked arthrogryposis has traditionally been classified by clinical severity [<xref ref-type="bibr" rid="sma-xli.REF.hall.1982.81">Hall et al 1982</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Type I (severe lethal) X-linked arthrogryposis was described in males with severe congenital contractures, scoliosis, chest deformities, hypotonia, and characteristic facies who died in the first three months of life from respiratory insufficiency. Autopsy demonstrated a quantitative decrease in the number of lateral anterior horn cells [<xref ref-type="bibr" rid="sma-xli.REF.kizilates.2005.201">Kizilates et al 2005</xref>, <xref ref-type="bibr" rid="sma-xli.REF.dressman.2007.52">Dressman et al 2007</xref>]. A <italic toggle="yes">UBA1</italic> pathogenic variant was subsequently identified in one of these families (Family #4) [<xref ref-type="bibr" rid="sma-xli.REF.ramser.2008.188">Ramser et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p>Type II (moderately severe) X-linked arthrogryposis was described in males with severe contractures, bilateral ptosis, inguinal hernias, and cryptorchidism. These males had normal intellect [<xref ref-type="bibr" rid="sma-xli.REF.hall.1982.81">Hall et al 1982</xref>].</p>
              <p>A few males with severe X-linked arthrogryposis have demonstrated muscle histology with ultrastructural changes with membranous bodies. These individuals had severe psychomotor retardation, in contrast to individuals with the milder types, who had normal development [<xref ref-type="bibr" rid="sma-xli.REF.hennekam.1991.656">Hennekam et al 1991</xref>].</p>
            </list-item>
            <list-item>
              <p>Type III (resolving) X-linked arthrogryposis was described in males with mild to moderate contractures at birth that improved significantly over time. At birth, carrier females had contractures that were milder than in males; they resolved by the second decade of life [<xref ref-type="bibr" rid="sma-xli.REF.hall.1982.81">Hall et al 1982</xref>].</p>
            </list-item>
          </list>
          <p>In addition to the three types described by <xref ref-type="bibr" rid="sma-xli.REF.hall.1982.81">Hall et al [1982]</xref>, <xref ref-type="bibr" rid="sma-xli.REF.zori.1998.450">Zori et al [1998]</xref> reported a five-generation family in which multiple males were affected with a relatively mild form of non-progressive arthrogryposis affecting only the lower limbs. All had involvement of the knee joint, with either a flexion or extension defect; about half had involvement of the hip joint, including one with dislocated hips; and all but two had involvement of the ankle joints. The contractures resulted in gait impairment, but all affected individuals were ambulatory. Skeletal muscle biopsies from two affected individuals were essentially normal, and nerve conduction studies from one affected individual were normal. No female family members were affected. <xref ref-type="bibr" rid="sma-xli.REF.zori.1998.450">Zori et al [1998]</xref> noted that the phenotype in this family was most consistent with type III X-linked arthrogryposis described by <xref ref-type="bibr" rid="sma-xli.REF.hall.1982.81">Hall et al [1982]</xref>.</p>
          <p>In summary, over the last two decades, knowledge regarding X-linked clinical syndromes in which arthrogryposis is part of the clinical spectrum has grown tremendously. A number of these syndromes have associated hypotonia (for further review, see <xref ref-type="bibr" rid="sma-xli.REF.hall.2007">Hall [2007]</xref> and <xref ref-type="bibr" rid="sma-xli.REF.hall.2010">Hall [2010]</xref>). Further discussion of these syndromes is beyond the scope of this review. The degree to which <italic toggle="yes">UBA1</italic> pathogenic variants are associated with these syndromes is yet to be determined.</p>
        </sec>
      </sec>
      <sec id="sma-xli.Management">
        <title>Management</title>
        <sec id="sma-xli.Evaluations_Following_Initial_Di">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with X-linked infantile spinal muscular atrophy (XL-SMA), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Nutrition/feeding</p>
              <list list-type="bullet">
                <list-item>
                  <p>Determine if caloric intake is adequate.</p>
                </list-item>
                <list-item>
                  <p>Determine if dysphagia and/or fatigue during feeding are present [<xref ref-type="bibr" rid="sma-xli.REF.iannaccone.2007.974">Iannaccone 2007</xref>]; consider swallowing evaluation, especially if aspiration is suspected [<xref ref-type="bibr" rid="sma-xli.REF.wang.2007.1027">Wang et al 2007</xref>].</p>
                </list-item>
                <list-item>
                  <p>Determine if gastrostomy tube placement and fundoplication are indicated.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Respiratory function</p>
              <list list-type="bullet">
                <list-item>
                  <p>Assess respiratory rate, work of breathing, presence of paradoxic breathing, chest wall shape, and skin perfusion.</p>
                </list-item>
                <list-item>
                  <p>Perform baseline pulmonary studies to determine extent of restrictive airway disease and cough efficiency.</p>
                </list-item>
                <list-item>
                  <p>Perform sleep evaluation to assess for sleep-disordered breathing including nocturnal hypoventilation and oxygen desaturation [<xref ref-type="bibr" rid="sma-xli.REF.wang.2007.1027">Wang et al 2007</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Orthopedic evaluation to assess contractures</p>
            </list-item>
            <list-item>
              <p>Neurologic evaluation to assess muscle tone and help guide supportive management [<xref ref-type="bibr" rid="sma-xli.REF.iannaccone.2007.974">Iannaccone 2007</xref>]</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="sma-xli.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Management is similar to that for classic SMA type 0 and SMA type I, caused by mutation of <italic toggle="yes">SMN</italic>. See <related-object link-type="booklink" source-id="gene" document-id="sma" document-type="chapter">Spinal Muscular Atrophy</related-object>.</p>
          <p>
            <bold>Feeding/growth</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>If oral intake is not adequate, consider higher-calorie feeds and fat supplementation.</p>
            </list-item>
            <list-item>
              <p>If weight gain is inadequate or the child cannot feed appropriately, consider nasogastric and possibly gastrostomy-tube placement<bold>.</bold></p>
            </list-item>
            <list-item>
              <p>Watch for swallowing dysfunction and consider a formal swallowing evaluation, especially if coughing or choking and/or recurrent pneumonias are evident as they may be signs of aspiration.</p>
            </list-item>
            <list-item>
              <p>Manage gastroesophageal reflux disorder in the standard manner.</p>
            </list-item>
            <list-item>
              <p>Manage constipation (resulting from weak abdominal musculature and poor motility) with diet (fiber and water content).</p>
            </list-item>
          </list>
          <p>
            <bold>Respiratory</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Provide rigorous pulmonary toilet, supplemental oxygen, and noninvasive ventilatory support.</p>
            </list-item>
            <list-item>
              <p>Assist cough through mechanical devices or other means if the patient has ineffective cough.</p>
            </list-item>
            <list-item>
              <p>Secretion mobilization may be achieved through chest physiotherapy and postural drainage.</p>
            </list-item>
            <list-item>
              <p>Use oral suctioning as needed.</p>
            </list-item>
            <list-item>
              <p>Use oximetry to monitor the patient&#x02019;s oxygen exchange status [<xref ref-type="bibr" rid="sma-xli.REF.wang.2007.1027">Wang et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p>In some cases artificial ventilation and tracheostomy may be employed.</p>
            </list-item>
            <list-item>
              <p>As in classic SMA, discuss "do not attempt to resuscitate" status with the family before respiratory failure occurs. This discussion may begin earlier, but is appropriate when abdominal breathing is present and/or the forced vital capacity is less than 30%. See <related-object link-type="booklink" source-id="gene" document-id="sma" document-type="chapter">Spinal Muscular Atrophy</related-object> for further discussion of respiratory support in SMA.</p>
            </list-item>
          </list>
          <p><bold>Sleep.</bold> Perform a sleep study if sleep-disordered breathing is suspected. Manage accordingly.</p>
          <p><bold>Orthopedic.</bold> Orthopedic management and physical and occupational therapy are indicated to manage contractures and prevent development of further contractures related to muscle weakness.</p>
        </sec>
        <sec id="sma-xli.Prevention_of_Secondary_Complica">
          <title>Prevention of Secondary Complications</title>
          <p>Standard precautions against infection are appropriate.</p>
        </sec>
        <sec id="sma-xli.Surveillance">
          <title>Surveillance</title>
          <p>The guidelines described below closely follow those presented in the consensus statement for standard care in spinal muscular atrophy [<xref ref-type="bibr" rid="sma-xli.REF.wang.2007.1027">Wang et al 2007</xref>].</p>
          <p>Individuals with XL-SMA should be followed regularly by a physician familiar with this condition (e.g., a clinical geneticist). Other subspecialists involved in ongoing care include the neurologist, pulmonologist, orthopedist, physical and occupational therapists, nutritionist, and gastroenterologist as needed.</p>
          <p>Affected children should be followed at least monthly until the severity and disease course are more clearly delineated. Affected children frequently die in infancy or early childhood; their clinical status should be followed closely to optimize management, and so that the family has a good understanding of the progression and can make informed decisions.</p>
          <p>The following are indicated on a routine basis:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic evaluations to assess muscle tone and help guide supportive management</p>
            </list-item>
            <list-item>
              <p>Evaluation by a pulmonologist for evidence of progression of restrictive airway disease</p>
            </list-item>
            <list-item>
              <p>Monitoring of caloric intake and weight, linear growth, head circumference, and growth velocity</p>
            </list-item>
            <list-item>
              <p>Monitoring for scoliosis and kyphosis</p>
            </list-item>
          </list>
        </sec>
        <sec id="sma-xli.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="sma-xli.Related_Genetic_Counseling_Issue">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="sma-xli.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="sma-xli.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="sma-xli.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>X-linked infantile spinal muscular atrophy (XL-SMA) is inherited in an X-linked manner.</p>
        </sec>
        <sec id="sma-xli.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of the proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of an affected male will not have the disease nor will he be a carrier of the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>In a family with more than one affected individual, the mother of an affected male is an obligate carrier.</p>
            </list-item>
            <list-item>
              <p>If pedigree analysis reveals that the proband is the only affected family member, the mother may be a carrier or the affected male may have a <italic toggle="yes">de novo</italic> pathogenic variant, in which case the mother is not a carrier.</p>
            </list-item>
            <list-item>
              <p>When an affected male is the only affected individual in the family, the following possibilities regarding his mother's carrier status need to be considered:</p>
              <list list-type="bullet">
                <list-item>
                  <p>He has a <italic toggle="yes">de novo</italic> pathogenic variant in <italic toggle="yes">UBA1</italic> and his mother is not a carrier.</p>
                </list-item>
                <list-item>
                  <p>His mother has a <italic toggle="yes">de novo</italic> pathogenic variant in <italic toggle="yes">UBA1</italic>, either (a) as a "germline variant" (i.e., present at the time of her conception and therefore in every cell of her body); or (b) as "germline mosaicism" (i.e., present in some of her germ cells only).</p>
                </list-item>
                <list-item>
                  <p>His mother has a pathogenic variant that she inherited from a maternal female ancestor.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>
            <bold>Sibs of the proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs depends on the carrier status of the mother.</p>
            </list-item>
            <list-item>
              <p>If the mother of the proband has a pathogenic variant, the chance of transmitting it in each pregnancy is 50%. Male sibs who inherit the pathogenic variant will be affected; female sibs who inherit the pathogenic variant will be carriers and will usually not be affected.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of the proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Males with a severe phenotype do not generally survive.</p>
            </list-item>
            <list-item>
              <p>Males with milder phenotypes will pass the pathogenic variant to all of their daughters and none of their sons.</p>
            </list-item>
          </list>
          <p><bold>Other family members of the proband.</bold> The proband's maternal aunts may be at risk of being carriers and the aunts&#x02019; offspring, depending on their gender, may be at risk of being carriers or of being affected.</p>
        </sec>
        <sec id="sma-xli.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing of at-risk female relatives is possible if the pathogenic variant in the family has been identified.</p>
        </sec>
        <sec id="sma-xli.Related_Genetic_Counseling_Issue">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="sma-xli.Prenatal_Testing_and_Preimplanta">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the pathogenic variant has been identified in the family, prenatal diagnosis for a pregnancy at increased risk and preimplantation genetic diagnosis for XL-SMA are possible.</p>
        </sec>
      </sec>
      <sec id="sma-xli.Resources">
        <title>Resources</title>
      </sec>
      <sec id="sma-xli.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold> Two alternatively spliced transcript variants of <italic toggle="yes">UBA1</italic> have been described. The second variant differs in the 5' UTR compared to variant 1. Variants 1 and 2 encode the same protein. The gene consists of 26 exons with an alternative exon1a accounting for the alternative splicing. Translation begins in exon 2. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="sma-xli" object-id="sma-xli.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> See <xref ref-type="table" rid="sma-xli.T.uba1_pathogenic_variants_discu">Table 3</xref>. To date, all pathogenic variants detected have been in exon 15. Exon 15 encodes part of a highly conserved protein domain that interacts with gigaxonin.</p>
        <table-wrap id="sma-xli.T.uba1_pathogenic_variants_discu" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p><italic toggle="yes">UBA1</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_sma-xli.T.uba1_pathogenic_variants_discu_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_sma-xli.T.uba1_pathogenic_variants_discu_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_sma-xli.T.uba1_pathogenic_variants_discu_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequence</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_sma-xli.T.uba1_pathogenic_variants_discu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1617G&#x0003e;T</td>
                <td headers="hd_h_sma-xli.T.uba1_pathogenic_variants_discu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met539Ile</td>
                <td headers="hd_h_sma-xli.T.uba1_pathogenic_variants_discu_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=163659922">NM_003334.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=23510338">NP_003325.2</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_sma-xli.T.uba1_pathogenic_variants_discu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1639A&#x0003e;G</td>
                <td headers="hd_h_sma-xli.T.uba1_pathogenic_variants_discu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser547Gly</td>
              </tr>
              <tr>
                <td headers="hd_h_sma-xli.T.uba1_pathogenic_variants_discu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1731C&#x0003e;T</td>
                <td headers="hd_h_sma-xli.T.uba1_pathogenic_variants_discu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn577Asn</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn>
              <p>
                <xref ref-type="bibr" rid="sma-xli.REF.ramser.2008.188">Ramser et al [2008]</xref>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The protein encoded by <italic toggle="yes">UBA1</italic> catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation. It comprises 1058 amino acids.</p>
        <p><bold>Abnormal gene product.</bold> The variant c.1731C&#x0003e;T, which does not alter an amino acid (p.Asn577Asn), has been shown to alter methylation in the CpG dinucleotides of exon 15. Therefore, in the index cases of three families with XL-SMA, this c.1731C&#x0003e;T change results in one fewer methylated C nucleotide compared to normal. The complete disease mechanism related to the change in methylation is not yet understood [<xref ref-type="bibr" rid="sma-xli.REF.ramser.2008.188">Ramser et al 2008</xref>].</p>
      </sec>
      <sec id="sma-xli.References">
        <title>References</title>
        <sec id="sma-xli.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="sma-xli.Literature_Cited.reflist0">
            <ref id="sma-xli.REF.delong.1992.905">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>DeLong</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siddique</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>A large New England kindred with autosomal dominant neurogenic scapuloperoneal amyotrophy with unique features.</article-title>
                <source>Arch Neurol.</source>
                <volume>49</volume>
                <fpage>905</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">1520078</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.deng.2010.165">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Deng</surname>
                    <given-names>HX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fecto</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yau</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siddique</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedley-Whyte</surname>
                    <given-names>ET</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delong</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martina</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dyck</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siddique</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4.</article-title>
                <source>Nat Genet.</source>
                <year>2010</year>
                <volume>42</volume>
                <fpage>165</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20037587</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.dressman.2007.52">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dressman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahearn</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yariz</surname>
                    <given-names>KO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Basterrecha</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palau</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barmada</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meindl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wirth</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>EP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumbach-Reardon</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>X-linked infantile spinal muscular atrophy: clinical definition and molecular mapping.</article-title>
                <source>Genet Med.</source>
                <volume>9</volume>
                <fpage>52</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">17224690</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.felderhoffmueser.2002.718">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Felderhoff-Mueser</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grohmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harder</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stadelmann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000fc;hrer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Obladen</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Severe spinal muscular atrophy variant associated with congenital bone fractures.</article-title>
                <source>J Child Neurol.</source>
                <volume>17</volume>
                <fpage>718</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">12503654</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.frijns.1994.192">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Frijns</surname>
                    <given-names>CJM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Deutekom</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jennekens</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Dominant congenital benign spinal muscular atrophy.</article-title>
                <source>Muscle Nerve.</source>
                <volume>17</volume>
                <fpage>192</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8114789</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.gerritsen.2003">
              <mixed-citation publication-type="confproc">Gerritsen J, Estrella E., Ahearn ME, Yariz KO, Baumbach L. Fetal akinesia with anterior horn cell loss and congenital malformation in male siblings: Severe X-linked spinal muscular atrophy (XL-SMA) or a new disease entity? Abstract 1743. Los Angeles, CA: American Society of Human Genetics Annual Meeting. 2003.</mixed-citation>
            </ref>
            <ref id="sma-xli.REF.greenberg.1988.217">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fenolio</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hejtmancik</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armstrong</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willis</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shapira</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huntington</surname>
                    <given-names>HW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haun</surname>
                    <given-names>RL</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>X-linked Infantile Spinal Muscular Atrophy.</article-title>
                <source>Am J Dis Child.</source>
                <volume>142</volume>
                <fpage>217</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">3341327</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.grohmann.2003.719">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grohmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stolz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuelke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janetzki</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouvrier</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Maldergem</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goemans</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eichholz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosch</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grattan-Smith</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navarro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neitzel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polster</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topalo&#x0011f;lu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steglich</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guenther</surname>
                    <given-names>UP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudnik-Sch&#x000f6;neborn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000fc;bner</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1).</article-title>
                <source>Ann Neurol.</source>
                <volume>54</volume>
                <fpage>719</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">14681881</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.hall.2007">
              <mixed-citation publication-type="book">Hall JG. Arthrogryposes (multiple congenital contractures). In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR, eds. <italic toggle="yes">Emery and Rimoin's Principles and Practice of Medical Genetics</italic>. 5 ed. New York, NY: Churchill Livingstone; 2007:3785-856.</mixed-citation>
            </ref>
            <ref id="sma-xli.REF.hall.2010">
              <mixed-citation publication-type="book">Hall JG. Arthrogryposis. In: Cassidy SB, Allanson JE, eds. <italic toggle="yes">Management of Genetic Syndromes</italic>. 3 ed. Hoboken, NJ: Wiley and Sons; 2010:81-96.</mixed-citation>
            </ref>
            <ref id="sma-xli.REF.hall.1982.81">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reed</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camarano</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1982</year>
                <article-title>Three distinct types of X-linked arthrogryposis seen in 6 families.</article-title>
                <source>Clin Genet.</source>
                <volume>21</volume>
                <fpage>81</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">7200838</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.hennekam.1991.656">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Lookeren Campagne</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Visser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dingemans</surname>
                    <given-names>KP</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>A family with severe X-linked arthrogryposis.</article-title>
                <source>Eur J Pediatr.</source>
                <volume>150</volume>
                <fpage>656</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">1915520</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.hsi.2004.165">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hsi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <article-title>A comparison of the mutation spectra of Menkes disease and Wilson disease.</article-title>
                <source>Hum Genet.</source>
                <year>2004</year>
                <volume>114</volume>
                <fpage>165</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">14579150</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.iannaccone.2007.974">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Iannaccone</surname>
                    <given-names>ST</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Modern management of spinal muscular atrophy.</article-title>
                <source>J Child Neurol.</source>
                <volume>22</volume>
                <fpage>974</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17761652</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.kennerson.2010.343">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kennerson</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaler</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kowalski</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercer</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Llanos</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takata</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speck-Martins</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baets</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Almeida-Souza</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherer</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferguson</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feely</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shy</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garbern</surname>
                    <given-names>JY</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>86</volume>
                <fpage>343</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">20170900</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.kizilates.2005.201">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kizilates</surname>
                    <given-names>SU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talim</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sel</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000f6;se</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caglar</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Severe lethal spinal muscular atrophy variant with arthrogryposis.</article-title>
                <source>Pediatr Neurol.</source>
                <volume>32</volume>
                <fpage>201</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">15730903</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.kobayashi.1995.1213">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumbach</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matise</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiavi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>EP</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>A gene for a severe lethal form of X-linked arthrogryposis (X-linked infantile spinal muscular atrophy) maps to human chromosome Xp11.3-q11.2.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>4</volume>
                <fpage>1213</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">8528211</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.m_kel_bengs.1998.506">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000e4;kel&#x000e4;-Bengs</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000e4;rvinen</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vuopala</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suomalainen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ignatius</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sipil&#x000e4;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herva</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palotie</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Assignment of the disease locus for lethal congenital contracture syndrome to a restricted region of chromosome 9q34, by genome scan using five affected individuals.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>63</volume>
                <fpage>506</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">9683599</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.nevo.1998.193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nevo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legum</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shomrat</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fatal</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soffer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shapira</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>SMA type 2 unrelated to chromosome 5q13.</article-title>
                <source>Am J Med Genet.</source>
                <volume>75</volume>
                <fpage>193</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9450884</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.nousiainen.2008.155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nousiainen</surname>
                    <given-names>HO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kestil&#x000e4;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pakkasj&#x000e4;rvi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honkala</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuure</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tallila</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vuopala</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ignatius</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herva</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease.</article-title>
                <source>Nat Genet.</source>
                <volume>40</volume>
                <fpage>155</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18204449</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.ramser.2008.188">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ramser</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahearn</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenski</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yariz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellebrand</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Rhein</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmutzler</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lichtner</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>EP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meindl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumbach-Reardon</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Rare missense and synonymous variants in UBE1 are associated with X-linked infantile spinal muscular atrophy.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>82</volume>
                <fpage>188</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">18179898</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.rietschel.1992.65">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rietschel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudnik-Schoneborn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Clinical variability of autosomal dominant spinal muscular atrophy.</article-title>
                <source>J Neurol Sci.</source>
                <volume>107</volume>
                <fpage>65</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">1578236</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.rudniksch_neborn.2003.10">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rudnik-Sch&#x000f6;neborn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sztriha</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aithala</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houge</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laegreid</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seeger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huppke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wirth</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Extended phenotype of pontocerebellar hypoplasia with infantile spinal muscular atrophy.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>117A</volume>
                <fpage>10</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12548734</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.ryan.2000.180">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ryan</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooke-Yarborough</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Procopis</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouvrier</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Anterior horn cell disease and olivopontocerebellar hypoplasia.</article-title>
                <source>Pediatr Neurol.</source>
                <volume>23</volume>
                <fpage>180</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11020648</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.takata.2004.224">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takata</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speck Martins</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passosbueno</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abe</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimura</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Da Silva</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monteiro</surname>
                    <given-names>A</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Lima</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kok</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zatz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A new locus for recessive distal spinal muscular atrophy at Xq13.1-q21.</article-title>
                <source>J Med Genet.</source>
                <volume>41</volume>
                <fpage>224</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14985388</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.wang.2007.1027">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finkel</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schroth</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simonds</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aloysius</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Main</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crawford</surname>
                    <given-names>TO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trela</surname>
                    <given-names>A</given-names>
                  </name>
                  <collab>Participants of the International Conference on SMA Standard of Care</collab>
                </person-group>
                <year>2007</year>
                <article-title>Consensus statement for standard of care in spinal muscular atrophy.</article-title>
                <source>J Child Neurol.</source>
                <volume>22</volume>
                <fpage>1027</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">17761659</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.zori.1998.450">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zori</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullan</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osborn</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>TP</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Newly described form of X-linked arthrogryposis maps to the long arm of the human X chromosome.</article-title>
                <source>Am J Med Genet.</source>
                <volume>78</volume>
                <fpage>450</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9714012</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="sma-xli.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="sma-xli.Suggested_Reading.reflist0">
            <ref id="sma-xli.REF.dubowitz.1991.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dubowitz</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Chaos in classification of the spinal muscular atrophies of childhood.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>1</volume>
                <fpage>77</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">1845352</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.markowitz.2012.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Markowitz</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darras</surname>
                    <given-names>BT</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Spinal muscular atrophy: a clinical and research update</article-title>
                <source>Pediatr Neurol.</source>
                <volume>46</volume>
                <fpage>1</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">22196485</pub-id>
              </element-citation>
            </ref>
            <ref id="sma-xli.REF.mercuri.2012.443">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mercuri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iannaccone</surname>
                    <given-names>ST</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Childhood spinal muscular atrophy: controversies and challenges.</article-title>
                <source>Lancet Neurol.</source>
                <volume>11</volume>
                <fpage>443</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">22516079</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="sma-xli.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="sma-xli.Acknowledgments">
          <title>Acknowledgments</title>
          <p>The authors are grateful to the numerous clinicians and families that have supported XL-SMA disease gene discovery efforts through their cooperation throughout the years (especially Dr Louis Elsas), as well as to the laboratories of Drs Alfons Meindl and Eric Hoffman, who share in the XL-SMA disease gene discovery. This work was supported in the United States by funds from the Dr John T Macdonald Center for Medical Genetics at the University of Miami Miller School of Medicine, the University of Miami Miller School of Medicine, the national Muscular Dystrophy Association, the Families of SMA, and Peyton&#x02019;s Pals; and in Europe, by the German Ministry for Research and Education grant and FAZIT-Stiftung, Frankfurt/Main, Germany. The authors would like to dedicate this review in memory of four human geneticists who were fundamental to the early days of this research project: Dr Frank Greenberg, Dr Ronald Haun, Dr Emmanuel Shapira, and especially Dr Victor McKusick, who thought every inherited disorder, common or rare, was worth recognition and further investigation.</p>
        </sec>
        <sec id="sma-xli.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>13 September 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>30 October 2008 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>10 July 2008 (lbr) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
